Abstract:Intrinsically disordered peptides, such as amyloid β42 (Aβ42), lack a well-defined structure in solution. Aβ42 can undergo abnormal aggregation and amyloidogenesis in the brain, forming fibrillar plaques, a hallmark of Alzheimer's disease. The insoluble fibrillar forms of Aβ42 exhibit well-defined, cross β-sheet structures at the molecular level and are less toxic than the soluble, intermediate disordered oligomeric forms. However, the mechanism of initial interaction of monomers and subsequent oligomerization is not well understood. The structural disorder of Aβ42 adds to the challenges of determining the structural properties of its monomers, making it difficult to understand the underlying molecular mechanism of pathogenic aggregation. Certain regions of Aβ42 are known to exhibit helical propensity in different physiological conditions. NMR spectroscopy has shown that the Aβ42 monomer at lower pH can adopt an α-helical conformation and as the pH is increased, the peptide switches to β-sheet conformation and aggregation occurs. CD spectroscopy studies of aggregation have shown the presence of an initial spike in the amount of α-helical content at the start of aggregation. Such an increase in α-helical content suggests a mechanism wherein the peptide can expose critical non-polar residues for interaction, leading to hydrophobic aggregation with other interacting peptides. We have used molecular dynamics simulations to characterize in detail the conformational landscape of monomeric Aβ42 in solution to identify molecular properties that may mediate the early stages of oligomerization. We hypothesized that conformations with α-helical structure have a higher probability of initiating aggregation because they increase the hydrophobicity of the peptide. Although random coil conformations were found to be the most dominant, as expected, α-helical conformations are thermodynamically accessible, more so than β-sheet conformations. Importantly, for the first time α-helical conformations are observed to increase the exposure of aromatic and hydrophobic residues to the aqueous solvent, favoring their hydrophobically driven interaction with other monomers to initiate aggregation. These findings constitute a first step toward characterizing the mechanism of formation of disordered, low-order oligomers of Aβ42.

A strand-loop-strand structure is a possible intermediate in fibril elongation: Long time simulations of amyloid-β peptide (10-35)

Fibril Elongation By A Beta(17-42): Kinetic Network Analysis Of Hybrid-Resolution Molecular Dynamics Simulations

Varied Probability of Staying Collapsed/Extended at the Conformational Equilibrium of Monomeric Aβ 40 and Aβ 42

Molecular Dynamics Studies of Hexamers of Amyloid-Beta Peptide (16-35) and Its Mutants: Influence of Charge States on Amyloid Formation

Varied Probability Of Staying Collapsed/Extended At The Conformational Equilibrium Of Monomeric A Beta(40) And A Beta(42)

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

Self-Assembly Pathways of Β-Sheet-rich Amyloid-β(1-40) Dimers: Markov State Model Analysis on Millisecond Hybrid-Resolution Simulations.

Modeling the Alzheimer Abeta17-42 Fibril Architecture: Tight Intermolecular Sheet-Sheet Association and Intramolecular Hydrated Cavities.

Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35

Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State

Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ <sub>16</sub> <sub>–</sub> <sub>22</sub> , Aβ <sub>16–35</sub> , and Aβ <sub>10</sub> <sub>–</sub> <sub>35</sub> ): Sequence effects

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation

Conformational Transition Of Amyloid Beta-Peptide

Stabilities And Conformations Of Alzheimer'S Beta-Amyloid Peptide Oligomers (A Beta(16-22 ') A Beta(16-35 ') And A Beta(10-35)): Sequence Effects

Different Protonated States at the C-terminal of the Amyloid-Β Peptide Modulate the Stability of S-shaped Protofibril

Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.

Structural Diversity of Dimers of the Alzheimer Amyloid-Beta(25-35) Peptide and Polymorphism of the Resulting Fibrils.

Ph-Dependent Conformational Ensemble and Polymorphism of Amyloid-Β Core Fragment.

An Atomic Model For The Pleated Beta-Sheet Structure Of A Beta Amyloid Protofilaments

Annular Structures As Intermediates in Fibril Formation of Alzheimer Abeta17-42.